Sarah Milner

Sarah Milner, PhD is a director of Scientific Writing at PTC Therapeutics where she specializes in rare metabolic diseases. Day-to-day, she manages and writes clinical documents for pre-IND/IND/NDA submissions. Since entering the world of writing after completing her PhD in 2009, Sarah has always worked in the rare disease space, working on successful submissions ranging from gene therapy to small molecules. She has a background in Molecular Biology across several fields including Dermatology, Gene Therapy, and Metabolic Disease.

Linked in profile: https://www.linkedin.com/in/sarah-milner-969b9515/

Contributions

The unique challenges of clinical trials in rare disease: A regulatory writer’s perspective - Volume 32, Issue 1

Designing clinical trials in rare diseases comes with a specific set of challenges including limited knowledge around the natural history of a disease, small sample size available for trial participation, regulatory guidance that is not calibrated…

Visit the EMWA website

Search

Links

The Write Stuff Archive Contact Instructions for Authors Article Template (Word) Journal Policies

Scope

Medical Writing is a quarterly publication that aims to educate and inform medical writers in Europe and beyond. Each issue focuses on a specific theme, and all issues include feature articles and regular columns on topics relevant to the practice of medical writing. We welcome articles providing practical advice to medical writers; guidelines and reviews/summaries/updates of guidelines published elsewhere; original research; opinion pieces; interviews; and review articles.

Medical Writing is listed in the following indexes: